Ketogenic Diet and Diabetes Demonstration Project
University of New Mexico · NCT06115265
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 40
- US sites recruiting
- 1
- Study start
- September 5, 2023
- Record last updated
- September 3, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
KDDP is a prospective, 12-month pilot study comparing the effects of a novel lifestyle program, the Ketogenic Diet and Diabetes Demonstration Project (KDDP) to those of the National Diabetes Prevention Program (NDDP). KDDP is modeled to mimic the delivery platform of NDPP with the exception that participants in KDDP will be placed on a medically-supervised ketogenic diet, and participants in NDPP will be placed on a low fat diet.
The purpose of this study is to compare the metabolic effects of the KDDP and the NDPP on glycemic control, lipid parameters, blood pressure, heart rate, weight, and coronary artery calcium scores in individuals with either type 2 diabetes or prediabetes.
Being studied: Ketogenic diet; Low Fat diet
Conditions: Type 2 Diabetes; PreDiabetes; Obesity; Ketogenic Dieting
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Men and women ≥ 18 years old
- BMI ≥27 kg/m2
- Hemoglobin A1c ≥ 5.7% and/or fasting plasma glucose of 100-125 mg/dL
Exclusion Criteria
- Known clinical cardiovascular disease (i.e. prior stroke, myocardial infarction, peripheral artery disease)
- LDL cholesterol ≥ 190 mg/dL
- Triglycerides ≥ 500 mg/dL
- History of type 1 diabetes
- History of diabetic ketoacidosis
- Individuals requiring insulin
- Advanced renal disease
- Advanced liver disease
- Terminal cancer
- Pregnancy
Recruiting US locations
University of New Mexico
Albuquerque, NM 87131
Site contact: Kristen Gonzales, MD · 505-272-3840 · KrGonzales@salud.unm.edu
Study contacts (from the official record)
- Kristen M Gonzales, MD · 505-272-3840 · KrGonzales@salud.unm.edu
- Matthew Bouchonville, MD · 505-272-3840 · mbouchonville@salud.unm.edu
Similar studies in New Mexico
All weight loss studies in New Mexico →- RecruitingPhase 3
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Pfizer
- Location
- Albuquerque, NM + 29 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
AstraZeneca
- Location
- Albuquerque, NM + 43 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Eli Lilly and Company
- Location
- Albuquerque, NM + 59 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Eli Lilly and Company
- Location
- Albuquerque, NM + 22 other US sites
- Eligibility basics
- Ages 18+